BioCentury
ARTICLE | Company News

DiagnoCure diagnostic news

April 29, 2013 7:00 AM UTC

DiagnoCure sent a letter to shareholders urging them to reelect its directors to the company's board after minority shareholders led by Todd Axelrod and Michael Rosenman proposed a slate of nominees for election. According to DiagnoCure, the group of dissident shareholders holds less than a 1% stake in the company but claim to hold more than 15% of outstanding shares. Five directors are up for reelection at the annual and special meeting on April 29. ...